174 related articles for article (PubMed ID: 18084035)
1. Studies on the mechanism of inhibition of bacterial ribonuclease P by aminoglycoside derivatives.
Kawamoto SA; Sudhahar CG; Hatfield CL; Sun J; Behrman EJ; Gopalan V
Nucleic Acids Res; 2008 Feb; 36(2):697-704. PubMed ID: 18084035
[TBL] [Abstract][Full Text] [Related]
2. Bacterial RNase P RNA is a drug target for aminoglycoside-arginine conjugates.
Berchanski A; Lapidot A
Bioconjug Chem; 2008 Sep; 19(9):1896-906. PubMed ID: 18712898
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of bacterial RNase P by aminoglycoside-arginine conjugates.
Eubank TD; Biswas R; Jovanovic M; Litovchick A; Lapidot A; Gopalan V
FEBS Lett; 2002 Jan; 511(1-3):107-12. PubMed ID: 11821058
[TBL] [Abstract][Full Text] [Related]
4. Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
Herzog IM; Louzoun Zada S; Fridman M
J Med Chem; 2016 Sep; 59(17):8008-18. PubMed ID: 27509271
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of protein synthesis by aminoglycoside-arginine conjugates.
Carriere M; Vijayabaskar V; Applefield D; Harvey I; Garneau P; Lorsch J; Lapidot A; Pelletier J
RNA; 2002 Oct; 8(10):1267-79. PubMed ID: 12403465
[TBL] [Abstract][Full Text] [Related]
6. Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat.
Yajima S; Shionoya H; Akagi T; Hamasaki K
Bioorg Med Chem; 2006 Apr; 14(8):2799-809. PubMed ID: 16413787
[TBL] [Abstract][Full Text] [Related]
7. A new class of branched aminoglycosides: pseudo-pentasaccharide derivatives of neomycin B.
Fridman M; Belakhov V; Yaron S; Baasov T
Org Lett; 2003 Oct; 5(20):3575-8. PubMed ID: 14507176
[TBL] [Abstract][Full Text] [Related]
8. A real-time fluorescence polarization activity assay to screen for inhibitors of bacterial ribonuclease P.
Liu X; Chen Y; Fierke CA
Nucleic Acids Res; 2014 Nov; 42(20):e159. PubMed ID: 25249623
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RNase P RNA cleavage by aminoglycosides.
Mikkelsen NE; Brännvall M; Virtanen A; Kirsebom LA
Proc Natl Acad Sci U S A; 1999 May; 96(11):6155-60. PubMed ID: 10339557
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of amphiphilic aminoglycoside-peptide triazole conjugates as antibacterial agents.
Bera S; Zhanel GG; Schweizer F
Bioorg Med Chem Lett; 2010 May; 20(10):3031-5. PubMed ID: 20413307
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step.
Borkow G; Vijayabaskar V; Lara HH; Kalinkovich A; Lapidot A
Antiviral Res; 2003 Nov; 60(3):181-92. PubMed ID: 14638394
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial activity of amphiphilic lysine-ligated neomycin B conjugates.
Bera S; Zhanel GG; Schweizer F
Carbohydr Res; 2011 Apr; 346(5):560-8. PubMed ID: 21353205
[TBL] [Abstract][Full Text] [Related]
13. Antisense inhibition of Escherichia coli RNase P RNA: mechanistic aspects.
Gruegelsiepe H; Willkomm DK; Goudinakis O; Hartmann RK
Chembiochem; 2003 Oct; 4(10):1049-56. PubMed ID: 14523923
[TBL] [Abstract][Full Text] [Related]
14. CuAAC-mediated diversification of aminoglycoside-arginine conjugate mimics by non-reducing di- and trisaccharides.
Westermann B; Dörner S; Brauch S; Schaks A; Heinke R; Stark S; van Delft FL; van Berkel SS
Carbohydr Res; 2013 Apr; 371():61-7. PubMed ID: 23507494
[TBL] [Abstract][Full Text] [Related]
15. New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues.
Zimmermann L; Das I; Désiré J; Sautrey G; Barros R S V; El Khoury M; Mingeot-Leclercq MP; Décout JL
J Med Chem; 2016 Oct; 59(20):9350-9369. PubMed ID: 27690420
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial activity of novel neamine derivatives.
Minowa N; Akiyama Y; Hiraiwa Y; Maebashi K; Usui T; Ikeda D
Bioorg Med Chem Lett; 2006 Dec; 16(24):6351-4. PubMed ID: 16997557
[TBL] [Abstract][Full Text] [Related]
17. Selectively guanidinylated aminoglycosides as antibiotics.
Fair RJ; Hensler ME; Thienphrapa W; Dam QN; Nizet V; Tor Y
ChemMedChem; 2012 Jul; 7(7):1237-44. PubMed ID: 22639134
[TBL] [Abstract][Full Text] [Related]
18. Branched aminoglycosides: biochemical studies and antibacterial activity of neomycin B derivatives.
Hainrichson M; Pokrovskaya V; Shallom-Shezifi D; Fridman M; Belakhov V; Shachar D; Yaron S; Baasov T
Bioorg Med Chem; 2005 Oct; 13(20):5797-807. PubMed ID: 15993084
[TBL] [Abstract][Full Text] [Related]
19. Functional reconstitution and characterization of Pyrococcus furiosus RNase P.
Tsai HY; Pulukkunat DK; Woznick WK; Gopalan V
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16147-52. PubMed ID: 17053064
[TBL] [Abstract][Full Text] [Related]
20. A simple structural-based approach to prevent aminoglycoside inactivation by bacterial defense proteins. Conformational restriction provides effective protection against neomycin-B nucleotidylation by ANT4.
Asensio JL; Hidalgo A; Bastida A; Torrado M; Corzana F; Chiara JL; García-Junceda E; Cañada J; Jiménez-Barbero J
J Am Chem Soc; 2005 Jun; 127(23):8278-9. PubMed ID: 15941249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
